SERA PROGNOSTICS, INC. Right-of-Use Asset Obtained in Exchange for Operating Lease Liability
SERA PROGNOSTICS, INC. (SERA) reported Right-of-Use Asset Obtained in Exchange for Operating Lease Liability of $12.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Notes › Leases
us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability · last filed 2026-08-12
- SERA PROGNOSTICS, INC. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2026-06-30 was $12.00K.
- SERA PROGNOSTICS, INC. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2026-03-31 was $17.00K.
- SERA PROGNOSTICS, INC. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2025-12-31 was $9.00K.
- SERA PROGNOSTICS, INC. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2025-09-30 was $2.27M.
- SERA PROGNOSTICS, INC. right-of-use asset obtained in exchange for operating lease liability for fiscal 2025 was $2.28M.
- SERA PROGNOSTICS, INC. right-of-use asset obtained in exchange for operating lease liability for fiscal 2024 was $0.00.
- SERA PROGNOSTICS, INC. right-of-use asset obtained in exchange for operating lease liability for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- SERA PROGNOSTICS, INC. right-of-use asset obtained in exchange for operating lease liability for fiscal 2022 was $2.17M.
| Period end | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 3 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 6 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 9 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2026-06-30 | $12.00K 10-Q · filed 2026-08-12 | $29.00K 10-Q · filed 2026-08-12 | $38.00K derived: sum of 3 quarters · filed 2026-08-12 | $2.31M derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | $17.00K 10-Q · filed 2026-05-06 | $26.00K derived: sum of 2 quarters · filed 2026-05-06 | $2.30M derived: sum of 3 quarters · filed 2026-05-06 | $2.30M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-12-31 | $9.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | $2.28M derived: sum of 2 quarters · filed 2026-03-18 | $2.28M derived: sum of 3 quarters · filed 2026-08-12 | $2.28M 10-K · filed 2026-03-18 |
| 2025-09-30 | $2.27M 10-Q · filed 2025-11-13 | $2.27M derived: sum of 2 quarters · filed 2026-08-12 | $2.27M 10-Q · filed 2025-11-13 | $2.27M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-06-30 | $0.00 10-Q · filed 2026-08-12 | $0.00 10-Q · filed 2026-08-12 | $0.00 derived: sum of 3 quarters · filed 2026-08-12 | $0.00 derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-03-31 | $0.00 10-Q · filed 2026-05-06 | $0.00 derived: sum of 2 quarters · filed 2026-05-06 | $0.00 derived: sum of 3 quarters · filed 2026-05-06 | $0.00 derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | $0.00 derived: sum of 2 quarters · filed 2026-03-18 | $0.00 derived: sum of 3 quarters · filed 2026-03-18 | $0.00 10-K · filed 2026-03-18 |
| 2024-09-30 | $0.00 10-Q · filed 2025-11-13 | $0.00 derived: sum of 2 quarters · filed 2025-11-13 | $0.00 10-Q · filed 2025-11-13 | $0.00 derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | $0.00 10-Q · filed 2024-08-07 | $0.00 10-Q · filed 2024-08-07 | $0.00 derived: sum of 3 quarters · filed 2025-05-07 | $0.00 derived: sum of 4 quarters · filed 2025-05-07 |
| 2024-03-31 | $0.00 10-Q · filed 2025-05-07 | $0.00 derived: sum of 2 quarters · filed 2025-05-07 | $0.00 derived: sum of 3 quarters · filed 2025-05-07 | $0.00 derived: sum of 4 quarters · filed 2025-05-07 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-19 | $0.00 derived: sum of 2 quarters · filed 2025-03-19 | $0.00 derived: sum of 3 quarters · filed 2025-03-19 | $0.00 10-K · filed 2025-03-19 |
| 2023-09-30 | $0.00 10-Q · filed 2024-11-06 | $0.00 derived: sum of 2 quarters · filed 2024-11-06 | $0.00 10-Q · filed 2024-11-06 | $1.72M derived: sum of 4 quarters · filed 2024-11-06 |
| 2023-06-30 | $0.00 10-Q · filed 2024-08-07 | $0.00 10-Q · filed 2024-08-07 | $1.72M derived: sum of 3 quarters · filed 2024-08-07 | $1.72M derived: sum of 4 quarters · filed 2024-08-07 |
| 2023-03-31 | $0.00 10-Q · filed 2024-05-08 | $1.72M derived: sum of 2 quarters · filed 2024-05-08 | $1.72M derived: sum of 3 quarters · filed 2024-05-08 | $1.72M derived: sum of 4 quarters · filed 2024-05-08 |
| 2022-12-31 | $1.72M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-20 | $1.72M derived: sum of 2 quarters · filed 2024-03-20 | $1.72M derived: sum of 3 quarters · filed 2024-03-20 | $2.17M 10-K · filed 2024-03-20 |
| 2022-09-30 | $0.00 10-Q · filed 2023-11-08 | $0.00 derived: sum of 2 quarters · filed 2023-11-08 | $453.00K 10-Q · filed 2023-11-08 | |
| 2022-06-30 | $0.00 10-Q · filed 2023-08-09 | $453.00K 10-Q · filed 2023-08-09 | ||
| 2022-03-31 | $453.00K 10-Q · filed 2023-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |